349-10-0 Usage
General Description
3-(Trifluoromethyl)mandelic Acid is a synthetic, organic compound that belongs to the class of compounds known as benzene and substituted derivatives, specifically a mono-benzenoid monocarboxylic acid carrying a trifluoromethyl group and a hydroxy group at position 3 and 2 respectively. Its formula is C9H7F3O3. As a fluorinated compound, it can have unique properties such as increased stability, decreased reactivity, and resistance to metabolic degradation, making it potentially useful in various chemical and pharmaceutical applications. However, specific information about its use, toxicity, and environmental effects is not readily available and requires further research. The structure of 3-(Trifluoromethyl)mandelic Acid is characterized by a trifluoromethyl group (-CF3) attached to a mandelic acid moiety.
Check Digit Verification of cas no
The CAS Registry Mumber 349-10-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,4 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 349-10:
(5*3)+(4*4)+(3*9)+(2*1)+(1*0)=60
60 % 10 = 0
So 349-10-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H7F3O3/c10-9(11,12)6-3-1-2-5(4-6)7(13)8(14)15/h1-4,7,13H,(H,14,15)
349-10-0Relevant articles and documents
PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS
-
, (2021/03/05)
Provided herein are compounds of formula (I) as shown below, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.
PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS TO TREAT VIRAL INFECTIONS
-
, (2021/11/20)
Provided herein are methods for treating a viral infection in a patient, comprising administering to said patient a therapeutically effective amount of a PERK inhibitor selected from a compound having the structure (I):
Enantioselective C-H Olefination of α-Hydroxy and α-Amino Phenylacetic Acids by Kinetic Resolution
Xiao, Kai-Jiong,Chu, Ling,Yu, Jin-Quan
, p. 2856 - 2860 (2016/02/27)
Significant progress has been made in the past decade regarding the development of enantioselective C-H activation reactions by desymmetrization. However, the requirement for the presence of two chemically identical prochiral C-H bonds represents an inherent limitation in scope. Reported is the first example of kinetic resolution by a palladium(II)-catalyzed enantioselective C-H activation and C-C bond formation, thus significantly expanding the scope of enantioselective C-H activation reactions.
